Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Clinical trial NCT01049399 · COMPLETED
Trial details
- NCT number
- NCT01049399
- Sponsor
- Noscira SA
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-09-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.